Kim Watson to Expand Global Partnerships for Clean Pesticide and Animal
MELBOURNE, Fla., March 17 /PRNewswire-FirstCall/ -- TyraTech (AIM: TYR), a pioneer of safer, effective and natural active ingredients for the pesticide, animal health and human functional food markets, announced today the appointment of Kim Watson as Senior Director Business Development. Watson will identify new commercial development partnerships and market opportunities to expand TyraTech's traction in the international institutional, agricultural, consumer, and animal and public health markets. In the newly created position, Watson will report to Stephen Briggs, Vice President Global Markets.
"TyraTech's growing line of active ingredient components for extremely effective products for the entire invertebrate pest control spectrum has positioned our company for numerous commercial opportunities. In order to capitalize on the breadth and strength of our proprietary technology, we are currently pursuing an aggressive growth strategy of major industry partnerships and licensing," said R. Douglas Armstrong, Ph.D., CEO of TyraTech. "An invaluable addition to our team, Watson brings specific experience in realizing both new market opportunities as well as paths to market through industry collaboration and partnership."
Watson has more than 20 years of experience in discovering, developing and commercializing new technologies in the agricultural chemical industry. Prior to joining TyraTech, Watson served as director of product acquisitions and licensing at FMC Corporation, a worldwide, diversified chemical company headquartered in Philadelphia. While at FMC, he was responsible for driving new business growth through acquisitions or licensing and secured exclusive access to several platform technologies. He also spent several years working with Bayer Australia, where he was a technical development officer and responsible for the marketing and distribution of proprietary agricultural chemicals. Watson is an active member in industry associations, including the Licensing Executives Society, and holds 18 technology patents of his own.
Steve Briggs added, "Our Company has seen a material increase in commercial and development capability with these key hires, which is complementing our already strong research and technology development resources." The addition of Mr. Watson complements other recent commercial market team additions at TyraTech which have included Dr. Peter Porpiglia, joining TyraTech from Kumiai Chemical as Sr. Director Product Development, and William Baxter, who moved from BASF as Sr. Director Market Development.
About TyraTech, Inc.
TyraTech is pioneering a new class of highly effective, non-toxic, pesticides and anti-parasitic compounds to address global agriculture, horticulture, functional foods, healthcare and veterinary markets. Using a revolutionary chemoreceptor screening process, TyraTech has identified proprietary blends of natural oils that stimulate the reactions and biological behaviour of insects and parasites so that they can be effectively repelled or killed. TyraTech's technology avoids the environmental concerns and human health risks as well as the development of resistance that are both associated with chemical pesticides, while still providing highly potent efficacy.
The Company's products have been validated through strong partnerships with multinational conglomerates operating within a growing US$23 billion worldwide market that is being increasingly driven by environmental legislation and end-user demand.
TyraTech continues to develop new product applications based on safe,
natural ingredients with a broad range of partners around the world.
Antenna Group (for TyraTech)
|SOURCE TyraTech, Inc.|
Copyright©2008 PR Newswire.
All rights reserved